|Articles|January 12, 2021
- Pharmaceutical Executive-01-01-2021
- Volume 41
- Issue 1
Pharmaceutical Executive, January 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive January 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
2021 in Focus: Pharm Exec’s Annual Industry Outlookover 5 years ago
Prescriber Hesitancy on COVID Vaccinesover 5 years ago
More Cloud on the Horizon for Pharmaover 5 years ago
A New Year for Sustainable Governanceover 5 years ago
Bound By Bloodover 5 years ago
Pharma in Spotlight as Pandemic Continues in 2021over 5 years ago
Six Degrees of 2020over 5 years ago
Why Investing in Tech Education Is Importantover 5 years ago
Pharm Exec Hits 40Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
5